Human T-leukemia and T-lymphoma express glutamate receptor AMPA GluR3, and the neurotransmitter glutamate elevates the cancer-related matrix-metalloproteinases inducer CD147/EMMPRIN, MMP-9 secretion and engraftment of T-leukemia in vivo

References

• Harris N L, Jaffe E S, Diebold J, Flandrin G, Muller-Hermelink H K, Vardiman J, et al. World Health Organisation classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835–3849
   PubMed Web of Science ®Google Scholar
• Biswas C. Tumor cell stimulation of collagenase production by fibroblasts. Biochem Biophys Res Commun 1982; 109: 1026–1034
   PubMed Web of Science ®Google Scholar
• Toole B P. Emmprin (CD147), a cell surface regulator of matrix metalloproteinase production and function. Curr Top Dev Biol 2003; 54: 371–389
   PubMed Web of Science ®Google Scholar
• Gabison E E, Hoang-Xuan T, Mauviel A, Menashi S. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 2005; 87: 361–368
   PubMed Web of Science ®Google Scholar
• Iacono K T, Brown A L, Greene M I, Saouaf S J. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol 2007; 83: 283–295
   PubMed Web of Science ®Google Scholar
• Nabeshima K, Suzumiya J, Nagano M, Ohshima K, Toole B P, Tamura K, et al. Emmprin, a cell surface inducer of matrix metalloproteinases (MMPs), is expressed in T-cell lymphomas. J Pathol 2004; 202: 341–351
   PubMed Web of Science ®Google Scholar
• Chen X, Su J, Chang J, Kanekura T, Li J, Kuang Y H, et al. Inhibition of CD147 gene expression via RNA interference reduces tumor cell proliferation, activation, adhesion, and migration activity in the human Jurkat T-lymphoma cell line. Cancer Invest 2008; 26: 689–697
   PubMed Web of Science ®Google Scholar
• Ruiz S, Castro-Castro A, Bustelo X R. CD147 inhibits the nuclear factor of activated T-cells by impairing Vav1 and Rac1 downstream signaling. J Biol Chem 2008; 283: 5554–5566
   PubMed Web of Science ®Google Scholar
• Thorns C, Bernd H W, Hatton D, Merz H, Feller A C, Lange K. Matrix-metalloproteinases in Hodgkin lymphoma. Anticancer Res 2003; 23: 1555–1558
   PubMed Web of Science ®Google Scholar
• Zucker S, Hymowitz M, Rollo E E, Mann R, Conner C E, Cao J, et al. Tumorigenic potential of extracellular matrix metalloproteinase inducer. Am J Pathol 2001; 158: 1921–1928
   PubMed Web of Science ®Google Scholar
• Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, et al. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett 1998; 441: 88–92
   PubMed Web of Science ®Google Scholar
• Biswas C. Collagenase stimulation in cocultures of human fibroblasts and human tumor cells. Cancer Lett 1984; 24: 201–207
   PubMed Web of Science ®Google Scholar
• Sameshima T, Nabeshima K, Toole B P, Yokogami K, Okada Y, Goya T, et al. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000; 157: 177–184
   PubMed Web of Science ®Google Scholar
• Kanekura T, Chen X, Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520–528
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Banda M J, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996; 156: 1–4
   PubMed Web of Science ®Google Scholar
• Hidalgo M, Eckhardt S G. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst 2001; 93: 178–193
   PubMed Web of Science ®Google Scholar
• Overall C M, Kleifeld O. Towards third generation matrix metalloproteinase inhibitors for cancer therapy. Br J Cancer 2006; 94: 941–946
   PubMed Web of Science ®Google Scholar
• Besser M J, Ganor Y, Levite M. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both. J Neuroimmunol 2005; 169: 161–171
   PubMed Web of Science ®Google Scholar
• Chen A, Ganor Y, Rahimipour S, Ben-Aroya N, Koch Y, Levite M. The neuropeptides GnRH-II and GnRH-I are produced by human T cells and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med 2002; 8: 1421–1426
   PubMed Web of Science ®Google Scholar
• Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 1998; 95: 12544–12549
   PubMed Web of Science ®Google Scholar
• Levite M. Nervous immunity: neurotransmitters, extracellular K+ and T-cell function. Trends Immunol 2001; 22: 2–5
   PubMed Web of Science ®Google Scholar
• Levite M, Cahalon L, Hershkoviz R, Steinman L, Lider O. Neuropeptides, via specific receptors, regulate T cell adhesion to fibronectin. J Immunol 1998; 160: 993–1000
   PubMed Web of Science ®Google Scholar
• Levite M, Chowers Y, Ganor Y, Besser M, Hershkovits R, Cahalon L. Dopamine interacts directly with its D3 and D2 receptors on normal human T cells, and activates beta1 integrin function. Eur J Immunol 2001; 31: 3504–3512
   PubMed Web of Science ®Google Scholar
• Levite M. Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. Curr Opin Pharmacol 2008; 8: 460–471
   PubMed Web of Science ®Google Scholar
• Lescheid D W, Terasawa E, Abler L A, Urbanski H F, Warby C M, Millar R P, et al. A second form of gonadotropin-releasing hormone (GnRH) with characteristics of chicken GnRH-II is present in the primate brain. Endocrinology 1997; 138: 5618–5629
   PubMed Web of Science ®Google Scholar
• Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J Immunol 2003; 170: 4362–4372
   PubMed Web of Science ®Google Scholar
• Ganor Y, Teichberg V I, Levite M. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J Immunol 2007; 178: 683–692
   PubMedGoogle Scholar
• Taizi M, Deutsch V R, Leitner A, Ohana A, Goldstein R S. A novel and rapid in vivo system for testing therapeutics on human leukemias. Exp Hematol 2006; 34: 1698–1708
   PubMed Web of Science ®Google Scholar
• Schneider T, Osl F, Friess T, Stockinger H, Scheuer W V. Quantification of human Alu sequences by real-time PCR–an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clin Exp Metastasis 2002; 19: 571–582
   PubMed Web of Science ®Google Scholar
• Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 2006; 56: 359–367
   PubMed Web of Science ®Google Scholar
• Xia M, Gaufo G O, Wang Q, Sreedharan S P, Goetzl E J. Transduction of specific inhibition of HuT 78 human T cell chemotaxis by type I vasoactive intestinal peptide receptors. J Immunol 1996; 157: 1132–1138
   PubMed Web of Science ®Google Scholar
• Bordador L C, Li X, Toole B, Chen B, Regezi J, Zardi L, et al. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 2000; 85: 347–352
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhu P, Jiang J L, Zhang Q, Wu Z B, Yao X Y, et al. Involvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1. BMC Cell Biol 2005; 6: 25
   PubMed Web of Science ®Google Scholar
• Zhu P, Lu N, Shi Z G, Zhou J, Wu Z B, Yang Y, et al. CD147 overexpression on synoviocytes in rheumatoid arthritis enhances matrix metalloproteinase production and invasiveness of synoviocytes. Arthritis Res Ther 2006; 8: R44
   Google Scholar
• Berditchevski F, Chang S, Bodorova J, Hemler M E. Generation of monoclonal antibodies to integrin-associated proteins. Evidence that alpha3beta1 complexes with EMMPRIN/basigin/OX47/M6. J Biol Chem 1997; 272: 29174–29180
   PubMed Web of Science ®Google Scholar
• Demers M, Magnaldo T, St-Pierre Y. A novel function for galectin-7: promoting tumorigenesis by up-regulating MMP-9 gene expression. Cancer Res 2005; 65: 5205–5210
   PubMed Web of Science ®Google Scholar
• Arlt M, Kopitz C, Pennington C, Watson K L, Krell H W, Bode W, et al. Increase in gelatinase-specificity of matrix metalloproteinase inhibitors correlates with antimetastatic efficacy in a T-cell lymphoma model. Cancer Res 2002; 62: 5543–5550
   PubMed Web of Science ®Google Scholar
• Liang Q, Xiong H, Gao G, Xiong K, Wang X, Zhao Z, et al. Inhibition of basigin expression in glioblastoma cell line via antisense RNA reduces tumor cell invasion and angiogenesis. Cancer Biol Ther 2005; 4: 759–762
   PubMed Web of Science ®Google Scholar
• Wang L, Wu G, Yu L, Yuan J, Fang F, Zhai Z, et al. Inhibition of CD147 expression reduces tumor cell invasion in human prostate cancer cell line via RNA interference. Cancer Biol Ther 2006; 5: 608–614
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu N, Zhou J, Chen Z N, Zhu P. Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 1299–1310
   PubMed Web of Science ®Google Scholar
• Meldrum B S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000; 130: 1007S–1015S
   PubMed Web of Science ®Google Scholar
• Rzeski W, Turski L, Ikonomidou C. Glutamate antagonists limit tumor growth. Proc Natl Acad Sci USA 2001; 98: 6372–6377
   PubMed Web of Science ®Google Scholar
• Kawano N, Ishikawa F, Shimoda K, Yasukawa M, Nagafuji K, Miyamoto T, et al. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice. Leukemia 2005; 19: 1384–1390
   PubMed Web of Science ®Google Scholar
• Campbell S J, Perry V H, Pitossi F J, Butchart A G, Chertoff M, Waters S, et al. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilisation and recruitment to both the central nervous system and the liver. Am J Pathol 2005; 166: 1487–1497
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Di Filippo M, Candeliere A, Chiasserini D, Mattioni A, Tenaglia S, et al. Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients. J Neuroimmunol 2007; 188: 146–158
   PubMed Web of Science ®Google Scholar